Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Semnur Pharmaceuticals ( (SMNR) ) has shared an announcement.
Semnur Pharmaceuticals has updated its securities description following amendments to its Certificate of Incorporation and Bylaws since December 31, 2024. This update impacts the company’s filings with the SEC, aligning with the Securities Act of 1933 and the Securities Exchange Act of 1934.
More about Semnur Pharmaceuticals
Semnur Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on the development and commercialization of innovative pain management solutions.
Average Trading Volume: 295
Technical Sentiment Signal: Sell
Current Market Cap: $2.07B
See more data about SMNR stock on TipRanks’ Stock Analysis page.